Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Sponsor: Vanda Pharmaceuticals
Check if you qualify for this schizophrenia clinical trial in Atlanta, GA
If you're searching for schizophrenia treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.